BAIT
                         BCAT2
BCAM, BCATM, BCT2, PP18
                         branched chain amino-acid transaminase 2, mitochondrial
 
                         
                         
                         GO Process (3)
GO Function (1)
GO Component (2)
Gene Ontology Biological Process
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
                     PREY
                         PRKDC
DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, IMD26, XRCC7, p350
                         protein kinase, DNA-activated, catalytic polypeptide
 
                         
                         
                         GO Process (13)
GO Function (6)
GO Component (6)
Gene Ontology Biological Process
- DNA repair [TAS]
 - cellular protein modification process [TAS]
 - cellular response to insulin stimulus [IMP]
 - double-strand break repair [TAS]
 - double-strand break repair via homologous recombination [IBA]
 - double-strand break repair via nonhomologous end joining [TAS]
 - innate immune response [TAS]
 - negative regulation of protein phosphorylation [ISS]
 - peptidyl-serine phosphorylation [IDA]
 - positive regulation of transcription from RNA polymerase II promoter [IMP]
 - positive regulation of type I interferon production [TAS]
 - regulation of circadian rhythm [ISS]
 - signal transduction involved in mitotic G1 DNA damage checkpoint [IMP]
 
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
                     Negative Genetic
Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a more severe fitness defect or lethality under a given condition. This term is reserved for high or low throughput studies with scores.
Publication
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.
Identification of effective combination therapies is critical to address the emergence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasible. Here we introduce a CRISPR-based double knockout (CDKO) system that improves the efficiency of combinatorial genetic screening using an effective strategy for cloning and sequencing paired single guide RNA (sgRNA) libraries and a robust statistical scoring ... [more]
Nat. Biotechnol. Mar. 20, 2017; 0(); [Pubmed: 28319085]
 
             Quantitative Score
- -3.564 [Confidence Score]
 
Throughput
- High Throughput
 
Ontology Terms
- growth abnormality (HP:0001507)
 
Additional Notes
- CRISPR GI screen
 - Cell Line:K562 (EFO:0002067)
 - Experimental Setup:Timecourse
 - GIST: A-phenotypic negative genetic interaction
 - Library:Drug Target-CDKO CRISPRn library
 - Significance Threshold: q-value<0.05
 
Curated By
- BioGRID